摘要
通过对葛根素注射液上市后安全性监测历程的回顾和相关专题研究工作的总结,探讨不良反应信号的发现、监测方法、监管模式和监管效果的内在规律,提出在药品上市后监管工作中政府、制药企业和医疗机构各自责任与作用的建议。
By reviewing the post-market safety surveillance and summarizing the thematic study for puerarin injection,this paper discussed the ADR signal discovery and monitoring methodology,modality and efficacy of surveillance and the internal rules.It puts forward suggestions to the responsibility and functions of the government,pharmaceutical companies and medical institutions.
出处
《中国药物警戒》
2008年第4期208-211,共4页
Chinese Journal of Pharmacovigilance
关键词
葛根素
不良反应
监测
建议
puerarin
adverse drug reaction(ADR)
monitoring
suggestion